NOV 02, 2021 7:00 AM PDT

LiquidArray® technology for TB / Mycobacteria diagnostics and beyond

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  November 2, 2021
Time: 7:00am (PDT),  10:00am (EDT), 3:00pm (CET)
 
 
Tuberculosis and nontuberculous mycobacteria are an alarming and ongoing global issue which requires fast and innovative diagnostics in order to fight the further spread of the diseases. Dr. Sandra Burrack-Lange will present the innovative LiquidArray® technology from Bruker-Hain. Assays based on this technology generate a unique level of information and therefore sequencing-like depth of results. FluoroType® MTB 2.0 is a sensitive semi-quantitative molecular genetic assay for the detection of tuberculosis complex from direct and cultured samples. With the WHO-recommended FluoroType® MTBDR 2.0 a true MDR-TB testing from patient samples is possible: the assay identifies resistances to rifampicin and isoniazid as well as silent mutations within the rpoB gene. The respective mutations are shown in the result evaluation - so more than 50 mutations within the rpoB, inhA and katG genes are identified leading to up to 522 resistance patterns. We will present the complete workflow, from DNA isolation up to convenient result interpretation with the unique FluoroSoftware®. Furthermore, upcoming developments with LiquidArray® technology in the Mycobacteria field and beyond will be elaborated, as well as more syndromic panel PCR-based assays for other healthcare challenges. 
 
Learning Objectives
  • Discover innovative LiquidArray® technology for TB and MDR-TB testing
  • Introduction of TB and Mycobacteria diagnostics portfolio
  • Learn about the complete TB / Mycobacteria diagnostics workflow delivering reliable results
 
Please contact your local representative for availability in your country. Not for sale in the USA.
 
 
Join us for our other webinars in this series:
 
 
 
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
Loading Comments...
Show Resources